Research programme: anti-estrogen compounds - AVAX Technologies
Alternative Names: 6-MCDF; Alkyl-PCDFs research programme - AVAX Technologies; Anti-estrogen technologies research programme - AVAX Technologies; Polychlorodibenzofurans research programme - AVAX TechnologiesLatest Information Update: 16 Mar 2007
At a glance
- Originator Texas A&M University
- Developer AVAX Technologies; Texas A&M University
- Class
- Mechanism of Action Estrogen receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cancer